Chargement en cours...
New agents for the treatment of hepatitis C in patients co-infected with HIV
Pilot trials evaluating the efficacy and safety of the first licensed hepatitis C virus (HCV) protease inhibitors (PIs), boceprevir (BOC) and telaprevir (TVR), for the treatment of genotype 1 infection in HCV/HIV co-infected patients revealed similar results as in HCV mono-infected patients. HCV liv...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4040720/ https://ncbi.nlm.nih.gov/pubmed/25165545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2049936113479591 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|